Respiratory syncytial virus, or RSV, has long been the leading cause of infant hospitalization in Canada. While real-world ...

Research led by the Veterans Affairs Portland Health Care System in Portland, Oregon, found that a single dose of respiratory syncytial virus (RSV) vaccine reduced RSV infections and RSV-related ...

According to DataM Intelligence, the Respiratory Syncytial Virus (RSV) Market Size reached USD 1.95 billion in 2024 and is projected to advance to USD 4.54 billion by 2033, expanding at a strong CAGR ...

Background Respiratory syncytial virus (RSV) is an important cause of acute lower respiratory infections (ALRI) among under-5 ...

The science is sound and the evidence is clear; immunization plays a crucial role in helping to protect children’s health ...

Vaccination plays a vital role in protecting children from respiratory diseases.

New study shows RSV infection in early infancy can raise asthma risk later, especially in children with allergic family history, highlighting vaccine benefits ...

In a recent study posted to the medRxiv* preprint server, researchers examined predictors for hospitalization due to respiratory syncytial virus (RSV) infections to develop a clinical model for ...

Respiratory syncytial virus (RSV) is a common viral infection that may lead to serious complications in certain groups. Since 2023, vaccines are now available and are highly recommended, especially ...

Background. Despite the prevalence of respiratory syncytial virus (RSV) in adults hospitalized with acute respiratory infections, guidelines for the diagnosis and management of RSV have not been ...

Cases of acute respiratory illness (ARI) are on the rise. Dr Indu Khosla shared the possible causes of such infections, when ...